Evidence map›Paper›PMID 35873308›Full record

ReviewVacunas

Menstrual abnormalities after COVID-19 vaccines: A systematic review.

Maheen Nazir, Shumaila Asghar, Muhammad Ali Rathore, Asima Shahzad, Anum Shahid, Alishba Ashraf Khan, Asmara Malik, Tehniat Fakhar, Hafsa Kausar, Jahanzeb Malik

Open access · greenAbstract readReview
In one paragraph

Review in Vacunas. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 5 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 5 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Menstrual Cycle Disturbances after COVID-19 Vaccination: A Cross-Sectional Study.International journal of fertility & sterility · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Maheen NazirDepartment of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
Shumaila AsgharDepartment of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
Muhammad Ali RathoreDepartment of Hematology, Armed Forces Institute of Transfusion, Rawalpindi, Pakistan.
Asima ShahzadFaculty of Medical Sciences, Army Medical College, Rawalpindi, Pakistan.
Anum ShahidDepartment of Obs/Gyne, Shifa International Hospital, Islamabad, Pakistan.
Alishba Ashraf KhanDepartment of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
Asmara MalikDepartment of Community Medicine, National University of Medical Sciences, Rawalpindi, Pakistan.
Tehniat FakharDepartment of Medicine, Shifa Tameer e Millat University, Islamabad, Pakistan.
Hafsa KausarDepartment of Medicine, Shifa Tameer e Millat University, Islamabad, Pakistan.
Jahanzeb MalikDepartment of Electrophysiology, Armed Forces Institute of Cardiology, Rawalpindi, Pakistan.
Rawalpindi Medical University · PKArmed Forces Institute of Pathology · PKShifa Tameer-e-Millat University · PKArmy Medical College · PKNational University of Medical Sciences · PKShifa International Hospital · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this systematic review is to give a comprehensive interpretation of menstrual cycle changes after the COVID-19 vaccination. Additionally, it is imperative to assess reports of menstrual changes following vaccination to dispel concerns that COVID-19 vaccines hinder the likelihood of pregnancy in the long run. A literature review was conducted using digital databases to systematically identify the studies reporting any menstrual abnormalities after the COVID-19 vaccine. Detailed patient-level study characteristics including the type of study, sample size, administered vaccines, and menstrual abnormalities were abstracted. A total of 78 138 vaccinated females were included in this review from 14 studies. Of these, 39 759 (52.05%) had some form of a menstrual problem after vaccination. Due to the lack of published research articles, preprints were also included in this review. Menorrhagia, metrorrhagia, and polymenorrhea were the most commonly observed problems and the overall study-level rate of menstrual abnormality ranged from 0.83% to 90.9%. Age, history of pregnancy, systemic side-effects of COVID-19, smoking, and second dose of COVID-19 vaccine were predictors of menstrual problems after vaccination.

Indexed as

DysmenorrheaGynecologyMenorrhagiaPandemicSARS-COV-2

Identifiers

PMID35873308
PMCPMC9294036
OpenAlexW4285810534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.